The results from the peripheral blood experiment showed that CD44 cells were significantly reduced in healthy human GG carriers, which indicated that gene polymorphism may influence the shearing and splicing of CD44, leading to a decrease in the CD44 protein and affecting the body's susceptibility to breast cancer risk.17 Here, CD44 is linked to breast carcinoma.